Showing results (11-20 of 166) with videos related to
Sort By:
Pageof 17
Journal of Clinical Pharmacy and Therapeutics|March 10, 2018
Nature's first "atypical opioids": Kratom and mitragyninesR B Raffa, J V Pergolizzi, R Taylor, et al.Journal of Clinical Pharmacy and Therapeutics|May 4, 2018
Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs)R B Raffa, J V Pergolizzi, R Taylor, et al.Journal of Clinical Pharmacy and Therapeutics|July 30, 2014
'Selective' COX-1 or COX-2 NSAIDs: time to change a misleading measureR B Raffa, J A Gudin, S Nalamachu, et al.Drugs of Today (Barcelona, Spain : 1998)|June 24, 2010
Oxycodone combinations for pain reliefR B Raffa, J V Pergolizzi, D J Segarnick, et al.Journal of Clinical Pharmacy and Therapeutics|May 4, 2018
Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesiaU J Eke-Okoro, R B Raffa, J V Pergolizzi, et al.Journal of Clinical Pharmacy and Therapeutics|November 18, 2015
Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAsZ Li, J V Pergolizzi, R P Huttner, et al.Journal of Clinical Pharmacy and Therapeutics|October 6, 2017
The fentanyl family: A distinguished medical history tainted by abuseR B Raffa, J V Pergolizzi, J A LeQuang, et al.European Review for Medical and Pharmacological Sciences|December 5, 2015
Postoperative Pain Surveys in Italy from 2006 and 2012: (POPSI and POPSI-2)F Coluzzi, C Mattia, G Savoia, et al.Journal of Clinical Pharmacy and Therapeutics|July 7, 2011
Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairmentR B RaffaPageof 17